{"company":{"id":2363129,"name":"Enable Injections","domain":"enableinjections.com","url":"https://alion.io/company/enableinjections"},"section":"news","answer":"Enable Injections: 25 headlines on record, 0 headlines in the last 90 days. Its story counts 14 milestones.","figures":[{"label":"Headlines","value":"25"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"14"}],"blocks":[{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":14}],"story":[{"title":"Raised a round Venture round $30M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982526000003/"},{"title":"Partnership Incyte and Enable Injections Announce Strategic Partnership for enFuse On-Body Delivery System · enableinjections.com","url":"https://enableinjections.com/incyte-and-enable-injections-announce-strategic-partnership-for-enfuse-on-body-delivery-system/"},{"title":"Certified Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology · globenewswire","url":"https://globenewswire.com/news-release/2025/03/25/3048607/0/en/Enable-Injections-Announces-Regulatory-CE-Mark-Approval-in-Europe-for-enFuse-Technology.html"},{"title":"New executive Enable Injections Names Matthew Huddleston as Chief Commercial Officer · globenewswire","url":"https://globenewswire.com/news-release/2024/05/22/2886372/0/en/Enable-Injections-Names-Matthew-Huddleston-as-Chief-Commercial-Officer.html"},{"title":"New executive Enable Injections names new chief operating officer on heels of key FDA approval · bizjournals.com","url":"https://bizjournals.com/cincinnati/inno/stories/news/2024/02/07/enable-injections-david-kroekel-c-suite-enfuse.html"},{"title":"Raised a round Venture round $150M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982522000001/"},{"title":"Raised a round Venture round $30.7M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982518000002/"},{"title":"Raised a round Venture round $25M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000014/"},{"title":"Raised a round Venture round $5M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000003/"},{"title":"Raised a round Venture round $247k · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000006/"},{"title":"Raised a round Venture round $2M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000002/"},{"title":"Raised a round Venture round $23k · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000012/"},{"title":"Raised a round Venture round $2M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1619825/000161982516000011/"},{"title":"Founded"}],"as_of":"2026-11-22","cite":"Enable Injections, News. Alion, Nov 22, 2026. https://alion.io/company/enableinjections/news","html_url":"https://alion.io/company/enableinjections/news","json_url":"https://alion.io/company/enableinjections/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-22T19:18:27Z"}}